| Literature DB >> 29437708 |
Jiaqing Hao1, Fei Yan2, Yuwen Zhang1, Ashley Triplett1,3, Ying Zhang4, Debra A Schultz5, Yanwen Sun1, Jun Zeng1,6, Kevin A T Silverstein4, Qi Zheng7, David A Bernlohr8, Margot P Cleary2, Nejat K Egilmez1, Edward Sauter9, Shujun Liu10, Jill Suttles11, Bing Li11.
Abstract
Tumor-associated macrophages (TAM) play a critical role in cancer development and progression. However, the heterogeneity of TAM presents a major challenge to identify clinically relevant markers for protumor TAM. Here, we report that expression of adipocyte/macrophage fatty acid-binding protein (A-FABP) in TAM promotes breast cancer progression. Although upregulation of A-FABP was inversely associated with breast cancer survival, deficiency of A-FABP significantly reduced mammary tumor growth and metastasis. Furthermore, the protumor effect of A-FABP was mediated by TAM, in particular, in a subset of TAM with a CD11b+F4/80+MHCII-Ly6C- phenotype. A-FABP expression in TAM facilitated protumor IL6/STAT3 signaling through regulation of the NFκB/miR-29b pathway. Collectively, our results suggest A-FABP as a new functional marker for protumor TAM.Significance: These findings identify A-FABP as a functional marker for protumor macrophages, thus offering a new target for tumor immunotherapy. Cancer Res; 78(9); 2343-55. ©2018 AACR. ©2018 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29437708 PMCID: PMC5932212 DOI: 10.1158/0008-5472.CAN-17-2465
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701